Noncompliance of common drug list submission must penalize.

Published: 2003-05-30 06:57:00

Updated: 2003-05-30 06:57:00

The Korea Pharmaceutical Association (KPA) put forceful strategies for the government newly to establish a penal provision when the common prescription drug lists are not complied to submit as they are currently experiencing a lot of business difficulties and troubles caused by such a non-complia...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK